Frazier Management LLC Crinetics Pharmaceuticals, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$17.15 - $28.31 $23.7 Million - $39.2 Million
-1,384,293 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$19.35 - $28.41 $10.3 Million - $15.1 Million
532,987 Added 62.61%
1,384,293 $39.3 Million
Q3 2021

Nov 12, 2021
BUY
$16.88 - $25.23 $14.4 Million - $21.5 Million
851,306 New
851,306 $17.9 Million

Others Institutions Holding CRNX

# of Institutions
240
Shares Held
79.5M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.94B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email